Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 3
2017 1
2018 5
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S, Zocchi MR, Poggi A. Varesano S, et al. Front Immunol. 2018 May 8;9:998. doi: 10.3389/fimmu.2018.00998. eCollection 2018. Front Immunol. 2018. PMID: 29867975 Free PMC article.
How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.
Poggi A, Varesano S, Zocchi MR. Poggi A, et al. Among authors: varesano s. Front Immunol. 2018 Feb 19;9:262. doi: 10.3389/fimmu.2018.00262. eCollection 2018. Front Immunol. 2018. PMID: 29515580 Free PMC article. Review.
Evaluation of RET Gene Rearrangement by Fluorescence In Situ Hybridization in Malignant Mesothelioma.
Salvi S, Ravetti JL, Arena G, Musso C, Varesano S, Pistillo MP, Canessa PA, Ferro P, Fedeli F, Roncella S. Salvi S, et al. Among authors: varesano s. J Thorac Oncol. 2018 Jan;13(1):e12-e14. doi: 10.1016/j.jtho.2017.09.1957. J Thorac Oncol. 2018. PMID: 29258668 Free article. No abstract available.
FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma.
Salvi S, Varesano S, Boccardo S, Ravetti JL, Canessa PA, Pistillo MP, Ferro P, Fedeli F, Roncella S. Salvi S, et al. Among authors: varesano s. J Thorac Oncol. 2017 Aug;12(8):e116-e118. doi: 10.1016/j.jtho.2017.03.015. J Thorac Oncol. 2017. PMID: 28748818 Free article. No abstract available.
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer.
Di Mascolo D, Varesano S, Benelli R, Mollica H, Salis A, Zocchi MR, Decuzzi P, Poggi A. Di Mascolo D, et al. Among authors: varesano s. Cancers (Basel). 2019 Dec 31;12(1):104. doi: 10.3390/cancers12010104. Cancers (Basel). 2019. PMID: 31906080 Free PMC article.
Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.
Poggi A, Varesano S, Zocchi MR. Poggi A, et al. Among authors: varesano s. Front Immunol. 2018 Jun 11;9:1342. doi: 10.3389/fimmu.2018.01342. eCollection 2018. Front Immunol. 2018. PMID: 29923549 Free PMC article.
MET Gene Status in Malignant Mesothelioma Using Fluorescent In Situ Hybridization.
Varesano S, Salvi S, Boccardo S, Ravetti JL, Pistillo MP, Canessa PA, Ferro P, Fedeli F, Roncella S. Varesano S, et al. J Thorac Oncol. 2016 Feb;11(2):e28-30. doi: 10.1016/j.jtho.2015.10.019. J Thorac Oncol. 2016. PMID: 26811229 Free article. No abstract available.
Corrigendum: Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S, Zocchi MR, Poggi A. Varesano S, et al. Front Immunol. 2018 Jun 13;9:1343. doi: 10.3389/fimmu.2018.01343. eCollection 2018. Front Immunol. 2018. PMID: 29930560 Free PMC article.
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-EGFR and Anti-MET Therapies.
Salvi S, Varesano S, Boccardo S, Ravetti JL, Canessa PA, Pistillo MP, Ferro P, Fedeli F, Roncella S. Salvi S, et al. Among authors: varesano s. J Thorac Oncol. 2016 Jun;11(6):e78-80. doi: 10.1016/j.jtho.2016.03.001. J Thorac Oncol. 2016. PMID: 27211582 Free article. No abstract available.
IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade.
Pistillo MP, Carosio R, Banelli B, Morabito A, Mastracci L, Ferro P, Varesano S, Venè R, Poggi A, Roncella S. Pistillo MP, et al. Among authors: varesano s. Cell Mol Immunol. 2020 Apr;17(4):410-411. doi: 10.1038/s41423-019-0245-x. Epub 2019 Jun 19. Cell Mol Immunol. 2020. PMID: 31217525 No abstract available.
14 results
Jump to page
Feedback